SCHEMBL18623344

SCHEMBL18623344

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5ccc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c6ccccc56)c5ccccc45)cc3)n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.61
KMT2A Q03164 11/20 0.61
HPGD P15428 8/20 0.61
ALDH1A1 P00352 7/20 0.61
MAPT P10636 6/20 0.61
NTSR1 P30989 1/20 0.56
KDM4E B2RXH2 4/20 0.53
LMNA P02545 2/20 0.53
GLA P06280 1/20 0.53
ADORA2A P29274 2/20 0.49
ADORA1 P30542 2/20 0.49
ACACA Q13085 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131687 0.98 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21131686 0.98 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21131529 0.98 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18965335 0.96 MEN1 (0.65) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18623314 0.95 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18623311 0.95 MEN1 (0.62) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL21132136 0.95 MEN1 (0.67) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18118587 0.95 MEN1 (0.67) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18623299 0.95 MEN1 (0.61) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL14079805 0.93 MEN1 (0.63) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580994-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580994-B2 Compound and organic light-emitting device including the same VDAC1, TMEM109, ELOVL1 MEN1 1001/4885KMT2A 2874/4885HPGD 2887/4885
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME VDAC1, TMEM109, ELOVL1 MEN1 1001/4885KMT2A 2874/4885HPGD 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.